Prognostic factors in ductal pancreatic cancer

Langenbeck's Archives of Surgery

Volumn 383, Issue 2, 1998, Pages 129-133

  Yeo, C J ^a   Cameron, J L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Adjuvant chemoradiation therapy; p53 tumor suppressor gene; Pancreatic adenocarcinoma; Tumor DNA content

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; HUMAN; MOLECULAR GENETICS; PANCREAS CANCER; PANCREAS DUCT; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL RATE; VATER PAPILLA CARCINOMA;

EID: 0031665514     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230050104     Document Type: Review

References (26)

1. UICC (1987) TNM classification of malignant tumors. 4th edn. Springer, Berlin Herdelberg New York
2. Japan Pancreas Society (1987) General rules for surgical and pathological studies on cancer of the pancreas. 3rd edn. Kanehara, Tokyo
3. Japan Pancreas Society (1993) General rules for the study of pancreatic cancer. 4th edn. Kanehara, Tokyo
4. Allison DC, Bose KK, Hruban RH et al (1991) Pancreatic cancer cell DNA content correlates with long term survival after pancreaticoduodenectomy. Ann Surg 214: 648-656
5. Johansson B, Bardi G, Heim S et al (1992) Nonrandom chromosome rearrangements in pancreatic carcinomas. Cancer 69: 1674-1681
6. Griffin CA, Hruban RH, Long PP et al (1994) Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosomes Cancer 9: 93-100
7. Griffin CA, Hruban RH, Morsberger LA et al (1995) Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res 55: 2394-2399
8. Seymour AB, Hruban RH, Redston M, Caldas C, Powell SM, Kinzler KW, Yeo CJ, Kern SE (1994) Allelotype of pancreatic adenocarcinoma. Cancer Res 54: 2761-2764
9. Hahn SA, Seymour AB, Hoque ATMS, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fisher A, Yeo CJ, Hruban RH, Kern SE (1995) Allelotype of pancreatic cancer using xenograft enrichment. Cancer Res 55: 4670-4675
10. Brat DJ, Hahn SA, Griffin CA, Yeo CJ, Kern SE, Hruban RH (1997) The structural basis of molecular genetic deletions: An integration of classical cytogenetic and molecular analysis of pancreatic adenocarcinoma. Am J Pathol 150: 383-391
11. DiGiuseppe JA, Yeo CJ, Hruban RH (1996) Molecular biology and the diagnosis and treatment of adenocarcinoma of the pancreas. Adv Anat Pathol 3, 139-155
12. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE (1997) Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 57: 1731-1734
13. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221: 721-733
14. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow, LB, Abrams RA (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, outcomes. Ann Surg 226: 248-260
15. Yeo CJ, Cameron JL (1994) Arguments against radical (extended) resection for adenocarcinoma of the pancreas. Adv Surg 27. 273-284
16. Gordon TA, Burleyson GP, Tielsch JM, Cameron JL (1995) The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 221: 43-49
17. Sosa JA, Bowman HM, Bass EB, Yeo CJ, Lillemoe KD, Pitt HA, Gordon TA, Cameron JL (1997) Importance of hospital volume in the surgical management of pancreatic cancer. Surg Forum 48:584-586
18. Lieberman MD, Kilburn H, Lindsey M, Brennan MF (1995) Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 222: 638-645
19. Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD, Cameron JL (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single institution experience. Ann Surg 225: 621-636
20. Kaiser MH, Ellenberg SS (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120: 899-903
21. Gastrointestinal Tumor Study Group (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59: 2006-2010
22. Bosset J, Pay JJ, Giblet M et al (1992) Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: results of a prospective study. Radiother Oncol 24: 191-194
23. Bakkevold KE, Arnesjo B, Dahl O, Kambestad B (1993) Adjuvant combined chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater - results of a controlled, prospective, randomized multicenter trial. Eur J Cancer 29A: 698-703
24. Geer RJ, Brennan MF (1993) Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165: 6873
25. Jaffee EM, Schutte M, Gossett J, Morsberger LA, Adler AJ, Thomas M, Greten TF, Hruban RH, Yeo CJ, Griffin CA (1998) Development and characterization of cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J Sci Am (in press)
26. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemore KD, Pitt HA (1998) Periampullary adenocarcinoma: Analysis of 5-year survivors. Ann Surg (in press)